Director Daniel Weiner Sells 3,250 Shares of Simulations Plus Inc (SLP)
Simulations Plus(SLP.US) Director Sells US$157.01K in Common Stock
$Simulations Plus(SLP.US)$ Director WEINER DANIEL L sold 3,250 shares of common stock on May 7, 2024 at an average price of $48.31 for a total value of $157.01K.Source: Announcement What is statement
Simulations Plus(SLP.US) Director Sells US$31,395 in Common Stock
$Simulations Plus(SLP.US)$ Director LaVange Lisa sold 650 shares of common stock on May 7, 2024 at an average price of $48.3 for a total value of $31,395.Source: Announcement What is statement of chan
Form 144 | Simulations Plus(SLP.US) Director Proposes to Sell 156.68K in Common Stocks
SEC FILLINGS DISCLOSED/ May 7, $Simulations Plus(SLP.US)$ Director DANIEL LEE WEINER intends to sell 3,250 shares of its common stock on May 7, with a total market value of approximately $156.68K.
Insider Sale at Simulations Plus Inc (SLP): Director and 10% Owner Walter Woltosz Sells 20,000 ...
Simulations Plus(SLP.US) 10% Shareholder Sells US$918.98K in Common Stock
$Simulations Plus(SLP.US)$ 10% Shareholder WOLTOSZ WALTER S sold 20,000 shares of common stock on May 1, 2024 at an average price of $45.95 for a total value of $918.98K. This transaction involves oth
Simulations Plus Insider Sold Shares Worth $918,984, According to a Recent SEC Filing
Walter S Woltosz, 10% Owner, Director, on May 01, 2024, sold 20,000 shares in Simulations Plus (SLP) for $918,984. Following the Form 4 filing with the SEC, Woltosz has control over a total of 3,580,8
Simulations Plus' (NASDAQ:SLP) Returns On Capital Not Reflecting Well On The Business
InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance
DELFT, Netherlands, April 17, 2024 /PRNewswire/ -- InnoGI Technologies (formerly The TIM Company) is pleased to announce an exciting, market-driven collaboration with Simulations Plus to combine its
Simulations Plus' (NASDAQ:SLP) Earnings Seem To Be Promising
Shareholders appeared to be happy with Simulations Plus, Inc.'s (NASDAQ:SLP) solid earnings report last week. Looking deeper at the numbers, we found several encouraging factors beyond the headline p
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year
Recent Dividend Declarations
Company Symbol Yld Per Amount Payable Record Increased New Old EMCOR Group EME
Simulations Plus Second Quarter 2024 Earnings: Beats Expectations
Why Reliance Global Group Shares Are Trading Lower By Around 11%; Here Are 20 Stocks Moving Premarket
Shares of Reliance Global Group, Inc. (NASDAQ:RELI) fell sharply in today's pre-market trading after reporting financial results for the year ended Dec 31, 2023. Reliance Global Group posted a net l
Simulations Plus To Go Ex-Dividend On April 26th, 2024 With 0.06 USD Dividend Per Share
April 5th - $Simulations Plus(SLP.US)$ is trading ex-dividend on April 26th, 2024. Shareholders of record on April 29th, 2024 will receive 0.06 USD dividend per share on May 6th, 2024. The ex-divi
Sector Update: Health Care Stocks Slump Late Afternoon
Health care stocks fell late Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each dropping 1.3%. The iShares Biotechnology ETF (IBB) shed 1.4%. In
Simulations Plus Soars Some 25% Following FDA's License Renewal for Dilisym Software Platform
Shares of Simulations Plus on Thursday jumped to a seven-month high after the company said the licenses to its Dilisym software platform have been renewed by the Food and Drug Administration.
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of STAAR Surgical Company (NASDAQ:STAA) rose sharply during Thursday's session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%
Simulations Plus Stock Jumps 25% Amid FDA Renewal, Earnings Report
No Data